©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 114367
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114367
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114367
Table 2 High risk stratification according to the Kidney Disease: Improving Global Outcomes guidelines[2]
| Universal agreement (A) | Majority agreement (B) | Evidence from single study (C) |
| > 1 HLA mismatches | Younger recipient age – no age threshold; older donor age – no age threshold; Black ethnicity (in the United States); PRA > 0%; presence of DSA; blood group incompatibility; delayed onset of graft function, especially with ECD | Cold ischemia time > 24 hours |
- Citation: Kute VB, Balwani MR, Shrimali JB, Pasari A, Kher V, Patel MP, Chafekar D, Guditi S, Das P, Siddaiah GM, Godara SM, Bhargava V, Gupta A, Ramteke V, Deshpande N, Tolani P, Prasad N, Patil RK, Mohanka R, Mahajan S, Sharma S, Banerjee S, Engineer DP, Agarwal D, Kashiv P, Lahiri A, Khullar D, Srivastava A. Induction therapy in kidney transplant recipients: A consensus statement of Indian Society of Organ Transplantation. World J Transplant 2026; 16(1): 114367
- URL: https://www.wjgnet.com/2220-3230/full/v16/i1/114367.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i1.114367